Cargando…
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patien...
Autores principales: | Yang, Hyun, Woo, Hyun Young, Lee, Soon Kyu, Han, Ji Won, Jang, Bohyun, Nam, Hee Chul, Lee, Hae Lim, Lee, Sung Won, Song, Do Seon, Song, Myeong Jun, Oh, Jung Suk, Chun, Ho Jong, Jang, Jeong Won, Lozada, Angelo, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497665/ https://www.ncbi.nlm.nih.gov/pubmed/28494528 http://dx.doi.org/10.3350/cmh.2016.0071 |
Ejemplares similares
-
Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020) -
Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases
por: Jang, Bohyun, et al.
Publicado: (2016) -
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2023) -
Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
por: Joo, Yu Young, et al.
Publicado: (2019) -
Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2012)